Clinical impact of thyroglobulin (Tg) and Tg autoantibody (TgAb) measurements in needle washouts of neck lymph node biopsies in the management of patients with papillary thyroid carcinoma

Autor: Elza S. Ikejiri, Felipe Crispim, Danielle M. Andreoni, M Cecília Martins-Costa, Cleber P. Camacho, M. Conceição O. Mamone, Rui M. B. Maciel, Rosa Paula M. Biscolla, Teresa S. Kasamatsu, Cláudia C. D. Nakabashi
Jazyk: angličtina
Rok vydání: 2017
Předmět:
medicine.medical_specialty
Pathology
Endocrinology
Diabetes and Metabolism

medicine.medical_treatment
Biopsy
Fine-Needle

Fluoroimmunoassay
lcsh:Medicine
030209 endocrinology & metabolism
thyroglobulin
Gastroenterology
lcsh:Diseases of the endocrine glands. Clinical endocrinology
Thyroglobulin
Papillary thyroid cancer
Thyroid carcinoma
03 medical and health sciences
0302 clinical medicine
Predictive Value of Tests
Reference Values
Internal medicine
Biopsy
medicine
Carcinoma
Humans
papillary thyroid cancer
Thyroid Neoplasms
Lymph node
Thyroid cancer
neck lymph nodes
Autoantibodies
Ultrasonography
lcsh:RC648-665
medicine.diagnostic_test
business.industry
lcsh:R
Reproducibility of Results
medicine.disease
Carcinoma
Papillary

medicine.anatomical_structure
Fine-needle aspiration
Fine needle aspiration biopsy
Thyroid Cancer
Papillary

anti-thyroglobulin antibody
030220 oncology & carcinogenesis
Lymphatic Metastasis
Lymph Nodes
business
Neck
Zdroj: Archives of Endocrinology and Metabolism v.61 n.2 2017
Arquivos de Endocrinologia e Metabolismo
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM
Archives of Endocrinology and Metabolism, Volume: 61, Issue: 2, Pages: 108-114, Published: 13 FEB 2017
Archives of Endocrinology and Metabolism, Vol 61, Iss 2, Pp 108-114 (2017)
Popis: Objectives The presence of thyroglobulin (Tg) in needle washouts of fine needle aspiration biopsy (Tg-FNAB) in neck lymph nodes (LNs) suspected of metastasis has become a cornerstone in the follow-up of patients with papillary thyroid carcinoma (PTC). However, there are limited data regarding the measurement of anti-Tg antibodies in these washouts (TgAb-FNAB), and it is not clear whether these antibodies interfere with the assessment of Tg-FNAB or whether there are other factors that would more consistently justify the finding of low Tg-FNAB in metastatic LNs. Materials and methods We investigated 232 FNAB samples obtained from suspicious neck LNs of 144 PTC patients. These samples were divided according to the patient’s serum TgAb status: sTgAb- (n = 203 samples) and sTgAb+ (n = 29). The TgAb-FNAB levels were measured using two different assays. Tg-FNAB was also measured using two assays when low levels (< 10 ng/mL) were identified in the first assay of the metastatic LNs from the sTgAb+ samples. Results The TgAb-FNAB results were negative in both assays in all samples. Low levels of Tg-FNAB were identified in 11/16 of the metastatic LNs of the sTgAb+ patients and 16/63 of the sTgAb- patients (p < 0.05) using assay 1. The measurement of the Tg-FNAB levels using assay 2 indicated additional metastases in 5 LNs of the sTgAb+ patients. Conclusions Factors other than the presence of TgAb-FNAB may contribute to the higher number of metastatic LNs with undetectable Tg-FNAB in the sTgAb+ group. In addition, the measurement of Tg-FNAB using different assays was useful to enhance the diagnosis of metastatic LNs, particularly when cytological and Tg-FNAB results are discordant.
Databáze: OpenAIRE